Immunotherapy for the treatment of hepatocellular carcinoma: finally in clinical practice

Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):252-255. doi: 10.21037/hbsn-23-97. Epub 2023 Mar 31.

Ciro Celsa^{1

2}, Lucia Cerrito³, Leonardo Stella³, Roberta Ciccia¹, Giuseppe Cabibbo¹, Francesca Romana Ponziani^{3

4}

¹ Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy.
² Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy.
³ Digestive Disease Center-CEMAD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
⁴ Università Cattolica del Sacro Cuore, Rome, Italy.

No abstract available

Keywords: Hepatocellular carcinoma; immune-checkpoint inhibitors; immune-related adverse events; immunotherapy; systemic therapies.

Publication types